Comparison of volume guarantee and volume-controlled ventilation both using closed loop inspired oxygen in preterm infants: a randomised crossover study (CLIO-VG study)
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu klinické zkoušky, časopisecké články, randomizované kontrolované studie
PubMed
34233907
DOI
10.1136/archdischild-2021-321712
PII: archdischild-2021-321712
Knihovny.cz E-zdroje
- Klíčová slova
- neonatology, technology,
- MeSH
- jednotky intenzivní péče o novorozence MeSH
- klinické křížové studie MeSH
- kyslík terapeutické užití MeSH
- lidé MeSH
- neinvazivní ventilace MeSH
- novorozenec nedonošený * MeSH
- novorozenec MeSH
- oxygenoterapie metody MeSH
- oxymetrie metody MeSH
- syndrom respirační tísně novorozenců prevence a kontrola MeSH
- umělé dýchání metody MeSH
- ventilace umělá s přerušovaným přetlakem * MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- kyslík MeSH
OBJECTIVE: The objective of this study was to compare two different modes of ventilation in maintaining oxygen saturation (SpO2) in target range (90%-95%) in ventilated preterm infants cared for with automatic control of oxygen delivery (A-FiO2). DESIGN: A single-centre randomised crossover study. SETTINGS: A level III neonatal intensive care unit. PATIENTS: Preterm infants receiving mechanical ventilation and oxygen requirement >21%. INTERVENTIONS: Volume guarantee (VG) vs volume controlled ventilation (VCV) modes with automatic oxygen control (A-FiO2). OUTCOMES: The primary outcome of this study was the proportion of time spent with oxygen saturations in the target range (90%-95%) . RESULTS: Nineteen preterm infants with a median gestation age 25 weeks (IQR: 24-28) and birth weight 685 g (IQR: 595-980) were enrolled in the study. There was no significant difference in primary outcome of median proportion of time spent in target saturation between the two arms (72% (57-81) in VG vs 75% (58-83) in VCV; p=0.98). There was no significant difference in the secondary outcomes of time spent in SpO2 <80% (0.03% vs 0.14%; p=0.51), time spent in SpO2 >98% (0.50% vs 0.08%; p=0.54), the median FiO2 (31% vs 29%; p=0.51) or manual adjustments carried out between VG and VCV, respectively. The number of episodes of prolonged hypoxaemia and hyperoxaemia were similar in the two groups. CONCLUSION: There was no significant difference in time spent in target SpO2 range between VG and VCV when A-FiO2 was used as the FiO2 controller in this crossover randomised control study. TRIAL REGISTRATION NUMBER: NCT03865069.
Biomedical Technology Czech Technical University Prague Czech Republic
Medtrx org Lake Arrowhead California USA
Neonatal Intensive Care Unit James Cook University Hospital Middlesbrough UK
Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK
Citace poskytuje Crossref.org
ClinicalTrials.gov
NCT03865069